How do the devices work?
Two types of brain stimulation are available today. Each has FDA clearance for at least one medical purpose but is being used in clinical trials and “off label” to treat several medical conditions.
In TMS therapy, the physician positions the magnet to stimulate neurons in a specific area of the brain that is underactive in people with
depression.
Transcranial magnetic stimulation (TMS) uses a magnetic field generated by a coil in a paddle that is held against the patient’s head to stimulate specific areas of the brain. This form of therapy is also called repetitive TMS or rTMS because the magnet is turned on and off rapidly, creating an effect that feels as though someone is tapping on your head. The magnet emits loud noises as it is turned on and off, which requires people undergoing TMS therapy to wear earplugs during the 40-minute sessions. Side effects are usually limited to headaches and ringing in the ears.
Transcranial direct current stimulation (tDCS) transmits a weak current from a 9-volt battery (the size used in a smoke detector) through electrodes on the forehead or scalp. People who undergo tDCS may feel their scalp tingle and hear a humming noise. Each session lasts about 20 minutes.
Both TMS and tDCS are being used to treat the following:
Depression. TMS stimulates neurons in the prefrontal cortex, a region of the brain that is underactive in people with depression. TMS received FDA clearance in 2008 for treating people with depression for whom drugs haven’t been effective. It may also be an alternative for women with depression who are pregnant or breastfeeding and thus may not want to take antidepressants. Unlike electro-convulsive therapy, which is also approved for depression that isn’t alleviated by medication, TMS isn’t likely to cause seizures or memory loss. Insurance may cover TMS therapy.
TDCS, which is FDA-cleared only to speed the absorption of certain medications through the skin, is also being used to treat depression. Because tDCS is still considered experimental, insurance won’t pay for this therapy for depression or any other condition.
Chronic pain. In a recent review of several randomized controlled clinical trials of TMS, Harvard re-searchers concluded that it was effective in treating nerve pain, including back and leg pain, pain and numbness in hands and feet caused by diabetes, and fibromyalgia. Although there are fewer data for tDCS, it may also be effective for those conditions.
Damage from stroke. Preliminary research suggests that TMS and tDCS may improve a person’s ability to move and speak and to overcome what’s called spatial neglect—the inability to notice or recognize objects on one side of the body. (Stroke damage on the right side of the brain affects the visual field on the left.)
Eating disorders. In early studies, both TMS and tDCS have reduced episodes of binge eating and bulimia in women with those eating disorders.
Migraine. A portable device that delivers a different type of TMS has received FDA clearance for treating migraine headache with aura (headache preceded by flashes of light, tingling, or other sensory disturbances). The manufacturer is conducting post-marketing studies at several headache centers before making it available by prescription.
Tinnitus. Researchers are exploring new ways to deliver TMS to reduce or eliminate the perception of ringing in the ears or other sounds within the head.
Memory and learning. In the last few years there have been scores of studies evaluating the effect of TMS or tDCS on people’s ability to perform mental tasks, particularly those that involve discerning visual patterns, re-calling lists of unrelated words, or doing math problems. Over all, the results indicate that the techniques are most likely to improve mental function when used in conjunction with other types of training, such as learning new systems for remembering names. A few small studies in people with mild Alzheimer’s disease suggest that TMS could be combined with cognitive exercises to improve function.